Citation

Claudia Goulston, W. McFarland, David Katzenstein. Human immunodeficiency virus type 1 RNA shedding in the female genital tract. Journal of Infectious Diseases. 1998. 177: 1100-3.

Citation

Patricia Reichelderfer, Anthony Japour, Lisa M. Demeter, Richard D'Aquila, Owen Weislow, Alejo Erice, Joseph Fitzgibbon, Robert Shafer, Douglas Richman, Yuqi Zhao, Diana Huang, Douglas Mayers, Max Arens, Kim Sannerud, Suraiya Rasheed, Daniel Kuritzkes. Interlaboratory concordance of DNA sequence analysis to detect drug reverse transciptase mutations in HIV-1 proviral DNA. Journal of Virological Methods. 1998. 75: 93-104.

Citation

G. Widmer, S. Tzipori, Carl J. Fichtenbaum, Jeff Griffiths. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. Journal of Infectious Diseases. 1998. 178: 834-40.

Citation

P. S. Eastman, David E. Shapiro, Robert W. Coombs, Lisa M. Frenkel, George D. McSherry, Paula Britto, Steven A. Herman, Rhoda S. Sperling. Maternal Viral Genotypic Zidovudine Resistance and Infrequent Failure of Zidovudine Therapy to Prevent Perinatal Transmission of HIV-1 in Pediatric AIDS Clinical Trials Group Protocol 076. Journal of Infectious Diseases. 1998. 177: 557-64.

Citation

Frank Palella, K. M. Delaney, A. C. Moorman, Mark O. Loveless, Jack Fuhrer, G. A. Satten, D. J. Aschman, S. D. Holmberg. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. New England Journal of Medicine. 1998. 338: 853-60.

Citation

David J. Straus, Jenny Huang, Marcia A. Testa, Alexandra M. Levine, Lawrence D. Kaplan. Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. Journal of Clinical Oncology. 1998. 16: 3601-6.

Citation

Genevieve Chene, Philippe Morlat, Catherine Leport, Richard Hafner, L. Dequae, I. Charreau, Jean-Pierre Aboulker, Benjamin J. Luft, Jean Aubertin, Jean-Louis Vilde, Roger Salamon. Intention-to-treat vs. on-treatment analyses of clinical trial data: experience from a study of pyrimethamine in the primary prophylaxis of toxoplasmosis in HIV-infected patients. ANRS 005/ACTG 154 trial group. Controlled Clinical Trials. 1998. 19: 233-48.

Citation

Rhoda S. Sperling, David E. Shapiro, George D. McSherry, Paula Britto, Bethann Cunningham-Schrader, Mary Culnane, Robert W. Coombs, Gwendolyn B. Scott, Russell B. Van Dyke, William T. Shearer, Eleanor Jimenez, Clemente Diaz, Duane Harrison, Jean-Francois Delfraissy. Safety of the Maternal-Infant Zidovudine Regimen Utilized in the Pediatric AIDS Clinical Trial Group 076 Study. AIDS. 1998. 12: 1805-13.

Citation

JS Lambert, J McNamara, SL Katz, T Fenton, MH Kang, TC VanCott, R Livingston, E Hawkins, J Moye, W Borkowsky, D Johnson, R Yogev, AM Duliege, Donald P. Francis, Anne A. Gershon, Diane W. Wara, Natasha L. Martin, Myron Levin, George D. McSherry, Gale Smith. Safety and Immunogenicity of HIV Recombinant Envelope Vaccines in HIV-infected Infants and Children. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1998. 19: 451-61.

Citation

Helen Kastrissios, J. R. Suarez, Scott M. Hammer, David Katzenstein, Terrence F. Blaschke. The extent of non-adherence in a large clinical trial using plasma dideoxynucleoside concentrations as a marker. AIDS. 1998. 12: 2305-11.